Chemotherapy of Basal Cell and Squamous Cell Carcinoma of the Eyelids and Periorbital Tissues
Authors:
- Malcolm N. LuxenbergMLMalcolm N. Luxenberg
- Troy H. GuthrieTGTroy H. Guthrie
- 1 April 1986
- journal article
- case report
- Published by Elsevier in Ophthalmology
- Vol. 93 (4) , 504-510
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cisplatin and doxorubicin. An effective chemotherapy combination in the treatment of advanced basal cell and squamous carcinoma of the skinCancer, 1985
- Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumorsCancer, 1984
- Responsiveness of metastatic basal-cell carcinoma to chemotherapy. A case reportCancer, 1983
- Successful systemic chemotherapy of advanced squamous and basal cell carcinoma of the skin with cis‐diamminedichloroplatinum iii and doxorubicinThe Laryngoscope, 1982
- Neurotoxic Effects of Cisplatin TherapyArchives of Neurology, 1982
- Ocular Side Effects of Cancer ChemotherapyCancer, 1982
- Eye toxicity of cancer chemotherapy: A review of the literatureCancer, 1981
- Cisplatin-associated cortical blindnessGynecologic Oncology, 1981
- Peripheral neuropathy and ophthalmologic toxicity after treatment with cis-dichlorodiaminoplatinum IIJournal of Cancer Research and Clinical Oncology, 1980
- Seizures and transient cortical blindness associated with cis-platinum (II) diamminedichloride (PDD) therapy in a thirty-year-old manCancer, 1980